ClinicalTrials.Veeva

Menu

Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation

Memorial Sloan Kettering Cancer Center (MSK) logo

Memorial Sloan Kettering Cancer Center (MSK)

Status

Completed

Conditions

Multiple Myeloma

Treatments

Other: Blood draw
Behavioral: Brief Test of Attention
Behavioral: Trail Making Test (Parts A & B)
Behavioral: The Center for Epidemiological Study-Depression
Behavioral: Hopkins Verbal Learning Test-Revised
Behavioral: The Functional Assessment of Chronic Illness Therapy-Fatigue Subscale, Version 4
Diagnostic Test: Functional Image
Behavioral: Digit Span subtest
Behavioral: Controlled Oral Word Association Test
Diagnostic Test: Structural Image
Behavioral: Auditory Consonant Trigrams Test

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to learn about possible changes in thinking (cognitive) abilities, such as memory skills, and in brain anatomy and function, in adults with multiple myeloma who are treated with high-dose chemotherapy followed by ASCT.

Enrollment

18 patients

Sex

All

Ages

60 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with multiple myeloma and in complete, partial or very good partial remission at enrollment as per standard International Myeloma Working Group Criteria

  • Scheduled to have high-dose chemotherapy and ASCT

  • Age 60 - 75 years at study entry

  • In the judgment of the consenting professional, fluent and able to communicate well enough in English to complete the study assessments and provide informed consent.

    • Patients who report that English is not their primary language will be asked the US Census English proficiency question "How well do you speak English" and the answer "very well" will be required

Exclusion criteria

  • With signs and/or symptoms of central nervous system cancers (e.g., tumors, metastases, leptomeningial disease) as determined by their physician, medical records, or by a brain MRI, either at the time of enrollment or during the study period
  • With current diagnosis of major Axis I psychiatric disorder (DSM-IV), major depression, bipolar disorder, or schizophrenia, as per medical records or patient report
  • As per patient report or as confirmed by the medical record, if the patient is taking anti-depression or anti-anxiety medication, < 2 months on these medications or a change in the prescribed dose in the past 2 months
  • With history of a neurological disorder, neurodegenerative disease, or traumatic brain injury with loss of consciousness (>60 minutes), as per medical records or patient report
  • With a history of another cancer, except for non-melanoma skin cancer, as per medical records or patient report
  • With current substance abuse and/or history of substance abuse, as per medical records or patient report
  • With evidence of visual or auditory impairment that would preclude completion of the assessments, as per medical records or patient report
  • With contraindications to MRI examinations as per standard screening guidelines used in the Department of Radiology (i.e., ferromagnetic material or implants, pacemakers or defibrillators, stents, claustrophobia)

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

18 participants in 1 patient group

rsfMRI + Neurocognitive Tests
Experimental group
Description:
Participants diagnosed with multiple myeloma in complete, partial or very good partial remission per standard International Myeloma Working Group Criteria will complete neurocognitive tests and structural and functional rsfMRI (brain MRIs).
Treatment:
Other: Blood draw
Diagnostic Test: Structural Image
Behavioral: Controlled Oral Word Association Test
Behavioral: Trail Making Test (Parts A & B)
Behavioral: Digit Span subtest
Behavioral: The Functional Assessment of Chronic Illness Therapy-Fatigue Subscale, Version 4
Behavioral: Hopkins Verbal Learning Test-Revised
Behavioral: The Center for Epidemiological Study-Depression
Behavioral: Brief Test of Attention
Behavioral: Auditory Consonant Trigrams Test
Diagnostic Test: Functional Image

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems